Quality measures for the care of patients with insomnia

Journal of Clinical Sleep Medicine

Volumn 11, Issue 3, 2015, Pages 311-334

  Edinger, Jack D ^a,b   Buysse, Daniel J ^c   Deriy, Ludmila ^d   Germain, Anne ^c   Lewin, Daniel S ^e   Ong, Jason C ^f   Morgenthaler, Timothy I ^g  

^a DEPARTMENT OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d American Academy of Sleep Medicine   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; DOXEPIN; ESZOPICLONE; GABAPENTIN; OLANZAPINE; QUETIAPINE; RAMELTEON; SUVOREXANT; TEMAZEPAM; TIAGABINE; TRIAZOLAM; ZALEPLON; ZOLPIDEM;

AFFECT; AMNESIA; ARTICLE; ASSESSMENT OF HUMANS; BALANCE IMPAIRMENT; BECK DEPRESSION INVENTORY; BEHAVIOR THERAPY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHILDREN SLEEP HABITS QUESTIONNAIRE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE THERAPY; COMORBIDITY; CONFUSION; CONSENSUS; DAYTIME FUNCTIONING; DAYTIME SOMNOLENCE; DEPRESSION; DISORIENTATION; DISTRESS SYNDROME; DIZZINESS; DRUG EFFICACY; EDUCATION; ENERGY; EPWORTH SLEEPINESS SCALE; EVIDENCE BASED PRACTICE; FALLING; FATIGUE; FATIGUE SEVERITY SCALE; FEEDBACK SYSTEM; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER 7; HEADACHE; HUMAN; INSOMNIA; INSOMNIA SEVERITY INDEX; MEDICAL DOCUMENTATION; MEDICAL RECORD; MOTIVATION; MULTICOMPONENT BEHAVIORAL THERAPY; MULTIDIMENSIONAL FATIGUE INVENTORY; NAUSEA; NIGHTMARE; OUTCOME ASSESSMENT; PARADOXICAL INTENTION; PATIENT HEALTH QUESTIONNAIRE 9; PITTSBURGH SLEEP QUALITY INDEX; PRACTICE GUIDELINE; PROFILE OF MOOD STATES; QUALITY OF LIFE; QUESTIONNAIRE; RAND 12; REBOUND; RELAXATION TRAINING; SATISFACTION; SEDATION; SHEEHAN DISABILITY SCALE; SHORT FORM 36; SLEEP DISORDER; SLEEP EATING; SLEEP PATTERN; SLEEP QUALITY; SLEEP RESTRICTION THERAPY; SLEEP SATISFACTION; SLEEP SELF REPORT; SLEEP WALKING; STATE TRAIT ANXIETY INVENTORY; TOTAL QUALITY MANAGEMENT; TRAFFIC ACCIDENT; TREATMENT OUTCOME; VOCATION; WITHDRAWAL SYNDROME; ADULT; HEALTH CARE QUALITY; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP MEDICINE; STANDARDS;

ADULT; HUMANS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP MEDICINE SPECIALTY; TREATMENT OUTCOME;

EID: 84924854937     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.4552     Document Type: Article

References (97)

1. American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
3. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985;42:225-32.
4. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479-84.
5. Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep 1999;22 Suppl 2:S366-372.
6. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 1997;31:333-46.
7. Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006;7:123-30.
8. Roth T, Coulouvrat C, Hajak G, et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry 2011;69:592-600.
9. Calhoun SL, Fernandez-Mendoza J, Vgontzas AN, Liao D, Bixler EO. Prevalence of insomnia symptoms in a general population sample of young children and preadolescents: gender effects. Sleep Med 2014;15:91-95.
10. Roberts RE, Roberts CR, Duong HT. Chronic insomnia and its negative consequences for health and functioning of adolescents: a 12-month prospective study. J Adolesc Health 2008;42:294-302.
11. Richardson GS. Managing insomnia in the primary care setting: raising the issues. Sleep 2000;23 Suppl 1:S9-12; discussion S13-15.
12. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998;158:1099-107.
13. Lacks P, Morin C. Recent advances in the assessment and treatment of insomnia. J Consult Clin Psychol 1992;60:586-94.
14. Fichten CS, Libman E, Bailes S, Alapin I. Characteristics of older adults with insomnia. In: Lichtstein KL, Morin CM, eds. Treatment of late-life insomnia. Thousand Oaks, CA: Sage, 2000:37-80.
15. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999;22:S379-85.
16. Gislason T, Almqvist M. Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men. Acta Med Scand 1987;221:475-81.
17. Vollrath M, Wicki W, Angst J. The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia. Eur Arch Psychiatry Neurol Sci 1989;239:113-24.
18. Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997;146:105-14.
19. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996;39:411-8.
20. Johnson EO, Roehrs T, Roth T, Breslau N. Epidemiology of alcohol and medication as aids to sleep in early adulthood. Sleep 1998;21:178-86.
21. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154:1417-23.
22. Weissman MM, Greenwald S, Nino-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997;19:245-50.
23. Buysse DJ, Tu XM, Cherry CR, et al. Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. Biol Psychiatry 1999;45:205-13.
24. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-5.
25. Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 1997;42:209-12.
26. Agargun MY, Kara H, Solmaz M. Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry 1997;58:249-51.
27. Johnson EO, Roth T, Breslau N. The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res 2006;40:700-8.
28. Palermo TM, Wilson AC, Lewandowski AS, Toliver-Sokol M, Murray CB. Behavioral and psychosocial factors associated with insomnia in adolescents with chronic pain. Pain 2011;152:89-94.
29. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22:S386-93.
30. Daley M, Morin CM, LeBlanc M, Gregoire JP, Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 2009;32:55-64.
31. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487-504.
32. Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep 2006;29:1155-73.
33. Morgenthaler TI. The quest for stability in an unstable world: adaptive servoventilation in opioid induced complex sleep apnea syndrome. J Clin Sleep Med 2008;4:321-3.
34. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL. Psychological and behavioral treatment of insomnia:update of the recent evidence (1998-2004). Sleep 2006;29:1398-414.
35. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebocontrolled study in adults with chronic insomnia. Sleep 2003;26:793-9.
36. Roehrs TA, Randall S, Harris E, Maan R, Roth T. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. J Psychopharmacol 2012;26:1088-95.
37. Buysse DJ, Young T, Edinger JD, Carroll J, Kotagal S. Clinician's use of the International Classification of Sleep Disorders (ICSD): results of a national survey. Sleep 2003;26:48-51.
38. Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: An update Sleep 2006 29 1415-1419
39. National Institutes of Health. National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005;28:1049-57.
40. Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010;24:1577-601.
41. Perlis ML, Smith MT. How can we make CBT-I and other BSM services widely available. J Clin Sleep Med 2008;4:11-13.
42. Espie CA. "Stepped care": a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep 2009;32:1549-58.
43. Edinger JD. Is it time to step up to stepped care with our cognitive-behavioral insomnia therapies? Sleep 2009;32:1539-41.
44. Manber R, Carney C, Edinger J, et al. Dissemination of CBTI to the nonsleep specialist: protocol development and training issues. J Clin Sleep Med 2012;8:209-18.
45. Ritterband LM, Bailey ET, Thorndike FP, Lord HR, Farrell-Carnahan L, Baum LD. Initial evaluation of an Internet intervention to improve the sleep of cancer survivors with insomnia. Psycho-oncology 2012;21:695-705.
46. Espie CA, Kyle SD, Williams C, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 2012;35:769-81.
47. Walsh JK, Schweitzer PK. Ten-year trends in the pharmacological treatment of insomnia. Sleep 1999;22:371-5.
48. Morgenthaler TI, Aronsky AJ, Carden KA, Chervin RD, Thomas SM, Watson NF. Measurement of quality to improve care in sleep medicine. J Clin Sleep Med 2015;11:279-91.
49. Southam-Gerow MA, Weisz JR, Chu BC, McLeod BD, Gordis EB, Connor-Smith JK. Does cognitive behavioral therapy for youth anxiety outperform usual care in community clinics? An initial effectiveness test. J Am Acad Child Adolesc Psychiatry 2010;49:1043-52.
50. James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2005(4):CD004690.
51. Cummings CM, Caporino NE, Settipani CA, et al. The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. J Consult Clin Psychol 2013;81:859-64.
52. Owens JA, Spirito A, McGuinn M. The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep 2000;23:1043-51.
53. Owens JA, Maxim R, Nobile C, McGuinn M, Msall M. Parental and self-report of sleep in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2000;154:549-55.
54. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297-307.
55. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
56. Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 1998;45:5-13.
57. Hedges DW, Brown BL, Shwalb DA. A direct comparison of effect sizes from the clinical global impression-improvement scale to effect sizes from other rating scales in controlled trials of adult social anxiety disorder. Hum Psychopharmacol 2009;24:35-40.
58. Bruni O, Ottaviano S, Guidetti V, et al. The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J Sleep Res 1996;5:251-61.
59. Wolfson AR, Carskadon MA, Acebo C, et al. Evidence for the validity of a sleep habits survey for adolescents. Sleep 2003;26:213-6.
60. Carney CE, Buysse DJ, Ancoli-Israel S, et al. The Consensus Sleep Diary: standardizing prospective sleep self-monitoring. Sleep 2012;35:287-302.
61. Kowalik J, Weller J, Venter J, Drachman D. Cognitive behavioral therapy for the treatment of pediatric posttraumatic stress disorder: a review and metaanalysis. J Behav Ther Exp Psychiatry 2011;42:405-13.
62. Rapp A, Dodds A, Walkup JT, Rynn M. Treatment of pediatric anxiety disorders. Ann N Y Acad Sci 2013;1304:52-61.
63. Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007;22:1335-50.
64. Buysse DJ. Insomnia. JAMA 2013;309:706-16.
65. Krakow B, Melendrez D, Lee SA, Warner TD, Clark JO, Sklar D. Refractory insomnia and sleep-disordered breathing: a pilot study. Sleep Breath 2004;8:15-29.
66. Guilleminault C, Davis K, Huynh NT. Prospective Randomized study of patients with insomnia and mild sleep disordered breathing. Sleep 2008;31:1527-33.
67. Edinger J, Bonnet M, Bootzin R, et al. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 2004;27:1567-96.
68. Anderson B, Storfer-Isser A, Taylor HG, Rosen CL, Redline S. Associations of executive function with sleepiness and sleep duration in adolescents. Pediatrics 2009;123:e701-707.
69. Gruber R, Laviolette R, Deluca P, Monson E, Cornish K, Carrier J. Short sleep duration is associated with poor performance on IQ measures in healthy school-age children. Sleep Med 2010;11:289-94.
70. Baum KT, Desai A, Field J, Miller LE, Rausch J, Beebe DW. Sleep restriction worsens mood and emotion regulation in adolescents. J Child Psychol Psychiatry 2014;55:180-90.
71. Morin CM. Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev 2003;7:263-79.
72. Buysse DJ, Cheng Y, Germain A, et al. Night-to-night sleep variability in older adults with and without chronic insomnia. Sleep Med 2010;11:56-64.
73. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
74. Krupp LB, Larocca NG, Muirnash J, Steinberg AD. The fatigue severity scale - application to patients with multiple-sclerosis and systemic lupuserythematosus. Arch Neurol 1989;46:1121-3.
75. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315-25.
76. Beck AT, Steer RA, Garbin MG. Psycometric properties of the Beck Depression Inventory - 25 years of evaluation. Clin Psychol Rev 1988;8:77-100.
77. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13.
78. Radloff LS. The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults. J Youth Adolesc 1991;20:149-66.
79. McNair DM, Lorr M, Droppleman LF. Profile of Mood States Manual. San Diego, CA: Educational and Industrial Testing Service, 1971.
80. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
81. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-7.
82. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996;11(Suppl 3):89-95.
83. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
84. Johnson JA, Maddigan SL. Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes. Qual Life Res 2004;13:449-56.
85. Melendres MC, Lutz JM, Rubin ED, Marcus CL. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics 2004;114:768-75.
86. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999;37:126-39.
87. Cohen M. The Revised Conners Parent Rating Scale: factor structure replication with a diversified clinical sample. J Abnorm Child Psychol 1988;16:187-96.
88. Wren FJ, Berg EA, Heiden LA, et al. Childhood anxiety in a diverse primary care population: parent-child reports, ethnicity and SCARED factor structure. J Am Acad Child Adolesc Psychiatry 2007;46:332-40.
89. Hodges KK, Siegel LJ, Mullins L, Griffin N. Factor analysis of the Children's Depression Inventory. Psychol Rep 1983;53(3 Pt 1):759-63.
90. Achenbach TM, Edelbrock CS. Behavioral problems and competencies reported by parents of normal and disturbed children aged four through sixteen. Monogr Soc Res Child Dev 1981;46:1-82.
91. Kyle SD, Miller CB, Rogers Z, Siriwardena AN, Macmahon KM, Espie CA. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep 2014;37:229-37.
92. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331:1169.
93. Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Morland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008;9:818-22.
94. Lader M. Benzodiazepines revisited-will we ever learn? Addiction 2011;106:2086-109.
95. Roehrs T, Roth T. Drug-related sleep stage changes: functional significance and clinical relevance. Sleep Med Clin 2010;5:559-70.
96. Greenblatt DJ, Roth T. Zolpidem for insomnia. Expert Opin Pharmacother 2012;13:879-93.
97. Gunja N. In the Zzz zone: the effects of Z-drugs on human performance and driving. J Med Toxicol 2013;9:163-71.